Humanised Igg1 Monoclonal Antibody Against Sez6, Conjugated To (2S)-2-(2-Bromoacetamido)-N-[(2S)-1-({3-[(7S)-7-Ethyl-7-Hydroxy-8,11-Dioxo-7,8,11,13-Tetrahydro-2H,10H-[1,3]Dioxolo[4,5-G]Pyrano[3',4':6,7]Indolizino[1,2-B]Quinolin-14-Yl]Bicyclo[1.1.1]Pentan-1-Yl}Amino)-1-Oxopropan-2-Yl]-3-Methylbutanamide

1 trials 1 recruiting

Filter these 1 trials by condition, phase, country and more.

Open in Search →
1 Registered trials
1 Recruiting
0 Completed trials
1 Sponsors
5 Countries
Phase II: 1

Indications tested

Small cell lung cancer 1

Sponsors using this IMP

AbbVie Deutschland GmbH & Co. KG 1

All trials

1 total

Showing 1–1 of 1 trials

← All drugs A–Z